Predicting the course of relapsing-remitting MS using longitudinal disability curves

Area of Science:

• Neurology
• Clinical Epidemiology

Background:

• Multiple sclerosis (MS) is a chronic, progressive central nervous system disease leading to neurological disability, typically in adults under 40.
• Monitoring MS progression is crucial for informed treatment decisions by physicians.
• Relapsing-remitting MS (RRMS) is a common disease course requiring careful management.

Purpose of the Study:

• To present longitudinal disability curves for assessing disease progression in patients with RRMS.
• To provide a tool for evaluating individual patient disability over time.
• To support clinical decision-making in the management of MS.

Main Methods:

• Identified patients with definite MS and an RR disease course from a specialized database.
• Stratified patients into percentile groups based on Expanded Disability Status Scale (EDSS) scores one year post-onset.
• Constructed model disability curves using smoothed (regression, moving averages) mean consecutive EDSS scores over 10 years post-onset.
• Validated predictive ability by superimposing data from a separate RRMS patient cohort.

Main Results:

• Developed longitudinal disability curves using data from 1001 patients.
• Demonstrated a significant difference between initial percentile assignment and subsequent disability progression (p < 0.001).
• Kaplan-Meier and life table analyses confirmed the model's validity in predicting disease progression.
• Showed reasonable predictive validity, with probabilities of deviating from predicted disability ranging from 1.6% to 15.4%.

Conclusions:

• Longitudinal disability curves are valuable for assessing individual patient disability in MS.
• These models can effectively map the impact of immunomodulatory treatments over time.
• The developed models serve as supportive tools for clinical decision-making in MS management.